<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://www.ajronline.org">
<title>American Journal of Roentgenology Genitourinary Imaging</title>
<link>http://www.ajronline.org</link>
<description>American Journal of Roentgenology RSS feed -- recent Genitourinary Imaging articles</description>
<prism:eIssn>1546-3141</prism:eIssn>
<prism:publicationName>American Journal of Roentgenology</prism:publicationName>
<prism:issn>0361-803X</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/1583?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/6/W497?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/1124?rss=1" />
  <rdf:li rdf:resource="http://www.ajronline.org/cgi/content/abstract/193/4/1128?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://www.ajronline.org/icons/banner/title.gif" />
</channel>

<image rdf:about="http://www.ajronline.org/icons/banner/title.gif">
<title>American Journal of Roentgenology</title>
<url>http://www.ajronline.org/icons/banner/title.gif</url>
<link>http://www.ajronline.org</link>
</image>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/1583?rss=1">
<title><![CDATA[MRI in the Detection of Prostate Cancer: Combined Apparent Diffusion Coefficient, Metabolite Ratio, and Vascular Parameters]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/1583?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to compare apparent
diffusion coefficients, metabolic ratios, and vascularity values within
histologically defined prostate tumors with those in nontumor tissue to
determine which functional parameter or combination of parameters is best for
differentiating tumor from nontumor tissue.</p>
<p><b>SUBJECTS AND METHODS.</b> Twenty patients due for prostatectomy
underwent endorectal MRI at 1.5 T. Transverse T2-weighted, diffusion-weighted,
2D chemical shift, and dynamic contrast-enhanced images were acquired. After
prostatectomy, the gland was sectioned transversely. Fresh slices and stained
whole-mount sections with histologically defined tumor outlines were
photographed. The tumor outlines were mapped onto images, and the apparent
diffusion coefficient (ADC), choline-to-citrate (Cho/cit) ratio, and
vascularity of the histologically defined tumor, normal peripheral zone, and
central gland were quantitatively measured. Area under the receiver operating
characteristics (ROC) curve (A<I><SUB>z</SUB></I>) was used to determine the
sensitivity and specificity of parameter combinations in cancer detection.</p>
<p><b>RESULTS.</b> In tumor regions larger than 1 cm<sup>2</sup>, the Cho/cit
ratio was higher in tumor than in nontumor tissue (<I>p</I> &lt; 0.001), in
the peripheral zone alone (<I>p</I> = 0.007), and in the central gland alone
(<I>p</I> = 0.005). ADC was lower and tumor vascularity greater in tumor
than in nontumor tissue (ADC, <I>p</I> = 0.003; initial area under the
gadolinium plasma concentration&ndash;time curve [initial gadolinium AUC],
<I>p</I> = 0.012; forward rate constant [K<sup>trans</sup>], <I>p</I> =
0.011; return rate constant [k<SUB>ep</SUB>], <I>p</I> = 0.036). No single
parameter had a significantly greater A<SUB><I>z</I></SUB> (ADC, 0.71;
Cho/cit ratio, 0.79; initial gadolinium AUC, 0.60; K<sup>trans</sup>, 0.62;
k<SUB>ep</SUB>, 0.65). Pairs of parameters, however, did increase
A<I><SUB>z</SUB></I>: ADC and initial gadolinium AUC (A<I><SUB>z</SUB></I>
= 0.94) versus ADC (<I>p</I> = 0.001) and initial gadolinium AUC (<I>p</I>
&lt; 0.001); ADC and Cho/cit ratio (A<SUB><I>z</I></SUB> = 0.94) versus ADC
(<I>p</I> = 0.001) and Cho/cit ratio (not significant); and Cho/cit ratio
and initial gadolinium AUC (A<I><SUB>z</SUB></I> = 0.88) versus Cho/cit
ratio (not significant) and initial gadolinium AUC (<I>p</I> &lt; 0.001).
All three functional techniques together had an A<I><SUB>z</SUB></I> of
0.95, showing no further improvement.</p>
<p><b>CONCLUSION.</b> The combination of two functional parameters is
associated with significant improvement in prostate cancer detection over use
of any parameter alone. Use of a third parameter does not increase the rate of
detection.</p>
]]></description>
<dc:creator><![CDATA[Riches, S. F., Payne, G. S., Morgan, V. A., Sandhu, S., Fisher, C., Germuska, M., Collins, D. J., Thompson, A., deSouza, N. M.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2540</dc:identifier>
<dc:title><![CDATA[MRI in the Detection of Prostate Cancer: Combined Apparent Diffusion Coefficient, Metabolite Ratio, and Vascular Parameters]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1591</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>1583</prism:startingPage>
<prism:section>Genitourinary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/6/W497?rss=1">
<title><![CDATA[18F-FDG PET/CT of Transitional Cell Carcinoma]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/6/W497?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The objective of this article is to provide a practical
illustrated review of PET/CT in the imaging evaluation of transitional cell
carcinoma.</p>
<p><b>CONCLUSION.</b> Local evaluation of the primary tumor in patients with
transitional cell carcinoma on PET is often limited by the obscuring effect of
excreted FDG, but assessment of metabolic activity may still be possible
through close correlation with CT images. PET/CT may also be helpful in the
detection of disease outside the bladder at nodal or more distant sites and in
the assessment of recurrent disease.</p>
]]></description>
<dc:creator><![CDATA[Patil, V. V., Wang, Z. J., Sollitto, R. A., Chuang, K.-W., Konety, B. R., Hawkins, R. A., Coakley, F. V.]]></dc:creator>
<dc:date>Fri, 20 Nov 2009 11:03:24 PST</dc:date>
<dc:identifier>info:doi/10.2214/AJR.08.1945</dc:identifier>
<dc:title><![CDATA[18F-FDG PET/CT of Transitional Cell Carcinoma]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>6</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>W504</prism:endingPage>
<prism:publicationDate>2009-12-01</prism:publicationDate>
<prism:startingPage>W497</prism:startingPage>
<prism:section>Genitourinary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/1124?rss=1">
<title><![CDATA[Frequency and Severity of Adverse Effects of Iodinated and Gadolinium Contrast Materials: Retrospective Review of 456,930 Doses]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/1124?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The purpose of this study was to determine the frequency
and characteristics of adverse effects of low-osmolar iodinated and gadolinium
contrast agents in a single-center experience with a large number of
cases.</p>
<p><b>MATERIALS AND METHODS.</b> A retrospective review of all intravascular
doses of low-osmolar iodinated and gadolinium contrast materials administered
from 2002 through 2006 was conducted. Adverse effects were identified through
the use of radiologist and nurse event recording. Adverse effects were
examined for type and severity of reaction, treatment required, and
outcome.</p>
<p><b>RESULTS.</b> A total of 456,930 contrast doses (298,491 low-osmolar
iodinated, 158,439 gadolinium) were administered over the study period. A
total of 522 cases of adverse effects (0.11% of total) were identified (458
low-osmolar iodinated, 64 gadolinium). The most common adverse effects were
hives (274, 52.5%) and nausea (92, 17.6%). Of all adverse effects, 79 of
low-osmolar iodinated and 15 of gadolinium contrast material necessitated
treatment. Most treatments were performed in the radiology department alone.
Only 16 cases of adverse effects necessitated transfer for further observation
or treatment. Epinephrine was used to manage an adverse effect in nine
instances. Thirty-two of the adverse effects of low-osmolar iodinated contrast
material (6.9%) occurred in patients with a history of allergy who received
premedication. Only two of these premedication reactions necessitated transfer
to the emergency department. The one death in the study period occurred after
administration of low-osmolar iodinated contrast material. The patient had no
symptoms during the contrast administration or imaging but died suddenly
within 30 minutes of receiving the dose.</p>
<p><b>CONCLUSION.</b> Both iodinated and gadolinium contrast agents are
associated with a very low rate of adverse effects. Most adverse effects are
mild and can be managed in the radiology department. Transfer for additional
treatment or observation is rarely needed.</p>
]]></description>
<dc:creator><![CDATA[Hunt, C. H., Hartman, R. P., Hesley, G. K.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:00 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2520</dc:identifier>
<dc:title><![CDATA[Frequency and Severity of Adverse Effects of Iodinated and Gadolinium Contrast Materials: Retrospective Review of 456,930 Doses]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1127</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1124</prism:startingPage>
<prism:section>Genitourinary Imaging</prism:section>
</item>

<item rdf:about="http://www.ajronline.org/cgi/content/abstract/193/4/1128?rss=1">
<title><![CDATA[Adrenal Imaging with MDCT: Nonneoplastic Disease]]></title>
<link>http://www.ajronline.org/cgi/content/abstract/193/4/1128?rss=1</link>
<description><![CDATA[
<p><b>OBJECTIVE.</b> The adrenal gland can enlarge or alter morphology in the
presence of a range of nonneoplastic entities, including hyperplasia,
hemorrhage, infection, or cystic mass. This article presents a description and
representative CT images for each of these disorders.</p>
<p><b>CONCLUSION.</b> Proper characterization is essential to ensure that
life-threatening sequelae from Addisonian crisis are averted in infection and
hemorrhage, or to identify "leave-alone" lesions such as
pseudocyst and chronic calcification.</p>
]]></description>
<dc:creator><![CDATA[Johnson, P. T., Horton, K. M., Fishman, E. K.]]></dc:creator>
<dc:date>Mon, 21 Sep 2009 11:03:01 PDT</dc:date>
<dc:identifier>info:doi/10.2214/AJR.09.2551</dc:identifier>
<dc:title><![CDATA[Adrenal Imaging with MDCT: Nonneoplastic Disease]]></dc:title>
<dc:publisher>American Roentgen Ray Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>193</prism:volume>
<prism:endingPage>1135</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>1128</prism:startingPage>
<prism:section>Genitourinary Imaging</prism:section>
</item>

</rdf:RDF>